Detection and drugresistance tendency of  extendedspectrum βlactamaseproducing Escherichia coli
DOI:
Author:
Affiliation:

Clc Number:

R378.2+1

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    ObjectiveTo investigate the detection and change in drugresistance of  extendedspectrum βlactamase (ESBLs)producing Escherichia coli, so as to provide reference for the rational use of antimicrobial agents in clinic.MethodsEscherichia coli isolated from clinic in a hospital between January~December, 2006 were collected, the detection of ESBLs  and drugresistance were compared with those of 2002. ResultsThe rate of ESBLsproducing Escherichia coli isolated in 2006 was 65.54% (175/267), which increased obviously compared with 47.92% (46/96) isolated  in 2002 (χ2=9.21, P<0.05). The susceptibility rate of ESBLsproducing Escherichia coli to imipenem in 2006 was 24.00%, which decreased obviously compared with 52.17% in 2002 (χ2=13.80, P<0.05); The susceptibility rates to the other antimicrobial agents had no statistic significance, imipenem still had ideal activity against ESBLsproducing Escherichia coli. ConclusionThere is increasing tendency in the detection of ESBLsproducing Escherichia coli, and drugresistance is high, which should be paid attention.

    Reference
    Related
Get Citation

张芳,李玉敏,崔琴,等.产ESBLs大肠埃希菌的检出与耐药趋势分析[J].中国感染控制杂志英文版,2009,8(3):195-197.
ZHANG Fang, LI Yumin, CUI Qin, et al. Detection and drugresistance tendency of  extendedspectrum βlactamaseproducing Escherichia coli[J]. Chin J Infect Control, 2009,8(3):195-197.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 22,2007
  • Revised:January 11,2008
  • Adopted:
  • Online: May 30,2009
  • Published: